Malgorzata Fuksiewicz (Małgorzata Fuksiewicz)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 9

Top Venues

Ginekologia polska

Cancers

Medical science monitor : international medical journal of experimental and clinical research

Journal of clinical pathology

Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology

Poland

PhD :: Laboratory of Tumor Markers, Department of Pathology and Laboratory Diagnostics,

Publications

Katarzyna Marcisz-Grzanka, Beata Kotowicz, Aleksandra Nowak, Mariola Winiarek, Malgorzata Fuksiewicz, Maria Kowalska, Andrzej Tysarowski, Tomasz Olesiński, Jakub Palucki, Urszula Sulkowska, Agnieszka Kolasinska-Cwikla, Lucjan Stanislaw Wyrwicz
Interleukin-6 as a Predictive Factor of Pathological Response to FLOT Regimen Systemic Treatment in Locally Advanced Gastroesophageal Junction or Gastric Cancer Patients. Cancers 16 (4) (2024)
Katarzyna Marcisz-Grzanka, Beata Kotowicz, Aleksandra Nowak, Mariola Winiarek, Malgorzata Fuksiewicz, Maria Kowalska, Andrzej Tysarowski, Tomasz Olesiński, Jakub Palucki, Urszula Sulkowska, Agnieszka Kolasinska-Cwikla, Lucjan Stanislaw Wyrwicz
Interleukin-6 as a Predictive Factor of Pathological Response to FLOT Regimen Systemic Treatment in Locally Advanced Gastroesophageal Junction or Gastric Cancer Patients. Cancers 16 (4) (2024)
Beata U Kotowicz, Malgorzata Fuksiewicz, Mariusz Bidzinski, Alicja Berezowska, Piotr Sobiczewski, Maria Małgorzata Kowalska
Measurement of HE4 six months after first-line treatment as optimal time in identifying patients at high risk of progression advanced ovarian cancer. Ginekologia polska 93 (11) (2023)
Beata U Kotowicz, Malgorzata Fuksiewicz, Mariusz Bidzinski, Alicja Berezowska, Piotr Sobiczewski, Maria Małgorzata Kowalska
Measurement of HE4 six months after first-line treatment as optimal time in identifying patients at high risk of progression advanced ovarian cancer. Ginekologia polska 93 (11) (2023)
Beata U Kotowicz, Waldemar Wierzba, Malgorzata Fuksiewicz, Jaroslaw Cwikla, Dorota Raczkiewicz, Mariusz Gujski, Szymon Piatek, Mariusz Bidzinski
Prognostic Factors for Uterine Sarcoma and Carcinosarcoma: Insights from a 10-Year Follow-Up Study. Medical science monitor : international medical journal of experimental and clinical research 29 (2023)
Beata U Kotowicz, Malgorzata Fuksiewicz, Mariusz Bidzinski, Alicja Berezowska, Piotr Sobiczewski, Maria Małgorzata Kowalska
Measurement of HE4 six months after first-line treatment as optimal time in identifying patients at high risk of progression advanced ovarian cancer. Ginekologia polska 93 (11) (2023)
Malgorzata Fuksiewicz, Maria Kowalska, Agnieszka Kolasinska-Cwikla, Beata Kotowicz
Serum levels of neuron-specific enolase as a prognostic factor for disease progression in patients with GET/NEN in the pancreas and the small intestine. Endocrine connections 11 (9) (2022)
Natalia Rusetska, Kamil Kowalski, Kamil Zalewski, Sebastian Zięba, Mariusz Bidzinski, Krzysztof Goryca, Beata U Kotowicz, Malgorzata Fuksiewicz, Janusz Kopczynski, Elwira Bakuła-Zalewska, Artur Kowalik, Magdalena Kowalewska
CXCR4/ACKR3/CXCL12 axis in the lymphatic metastasis of vulvar squamous cell carcinoma. Journal of clinical pathology (2021)
Malgorzata Fuksiewicz, Beata Kotowicz, Andrzej Rutkowski, Joanna Achinger-Kawecka, Michal Wagrodzki, Maria M Kowalska
The Assessment of Clinical Usage and Prognostic Value of YKL-40 Serum Levels in Patients With Rectal Cancer Without Distant Metastasis. Technology in cancer research & treatment 17 (2018)

Malgorzata Fuksiewicz.css-eqlu8i{font-size:small;padding-left:4px;} (Małgorzata Fuksiewicz)

Publication Activity (10 Years)

Top Topics

Top Venues

Malgorzata Fuksiewicz (Małgorzata Fuksiewicz)